ATF7IP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.823800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.767050E-01
Normal-vs-Stage2
4.428400E-02
Normal-vs-Stage3
2.472000E-01
Normal-vs-Stage4
7.039800E-01
Stage1-vs-Stage2
7.714000E-01
Stage1-vs-Stage3
3.397400E-01
Stage1-vs-Stage4
2.605200E-01
Stage2-vs-Stage3
2.385200E-01
Stage2-vs-Stage4
1.635970E-01
Stage3-vs-Stage4
1.116980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.621700E-02
Normal-vs-AfricanAmerican
3.176400E-01
Normal-vs-Asian
1.168780E-01
Caucasian-vs-AfricanAmerican
5.887800E-01
Caucasian-vs-Asian
4.678000E-01
AfricanAmerican-vs-Asian
4.466800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.804400E-02
Normal-vs-Female
3.669600E-01
Male-vs-Female
6.220400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.814600E-01
Normal-vs-Age(41-60Yrs)
1.340560E-01
Normal-vs-Age(61-80Yrs)
3.440600E-01
Normal-vs-Age(81-100Yrs)
1.216170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.866600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.083600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.758200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.780140E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.178400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.366000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.224100E-02
Normal-vs-Daily Drinker
2.869000E-01
Normal-vs-Weekly Drinker
3.024800E-01
Normal-vs-Occasional Drinker
1.803040E-01
Normal-vs-Social Drinker
1.947780E-01
Non Drinker-vs-Daily Drinker
4.274400E-01
Non Drinker-vs-Weekly Drinker
6.640400E-01
Non Drinker-vs-Occasional Drinker
2.924000E-01
Non Drinker-vs-Social Drinker
2.760800E-01
Daily Drinker-vs-Weekly Drinker
8.038400E-01
Daily Drinker-vs-Occasional Drinker
8.079500E-02
Daily Drinker-vs-Social Drinker
5.482200E-02
Weekly Drinker-vs-Occasional Drinker
1.656580E-01
Weekly Drinker-vs-Social Drinker
1.416620E-01
Occasional Drinker-vs-Social Drinker
9.420200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.008000E-01
Normal-vs-Grade 2
9.841700E-02
Normal-vs-Grade 3
5.014300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.763000E-01
Grade 1-vs-Grade 3
8.660500E-02
Grade 1-vs-Grade 4
2.008000E-01
Grade 2-vs-Grade 3
3.581200E-01
Grade 2-vs-Grade 4
9.841700E-02
Grade 3-vs-Grade 4
5.014300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.530000E-01
Normal-vs-NonDiabetic
2.458500E-02
Diabetic-vs-NonDiabetic
9.687800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.039200E-01
Normal-vs-NoPancreatitis
3.201600E-02
Pancreatitis-vs-NoPancreatitis
1.419230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.956500E-02
Normal-vs-N1
5.310200E-02
N0-vs-N1
4.728600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.754800E-01
Normal-vs-TP53-NonMutant
4.415600E-01
TP53-Mutant-vs-TP53-NonMutant
1.695400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
